If You Invested in HEMAB THERAPEUTICS HOLDINGS (COAG)
Looking for the live price? See the COAG quote & overviewWhat $1,000 or $10,000 in COAG Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since May 1, 2026 |
|---|---|---|---|---|
| $1,000 | — | — | — | $1,094 +9% |
| $10,000 | — | — | — | $10,941 +9% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for COAG$1,000 Investment Over Time
COAG vs S&P 500Year-by-Year Returns
COAG annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2026 | $34.00 | $37.20 | +9.4% | +9.4% |
About HEMAB THERAPEUTICS HOLDINGS
Biological Products, (no Diagnostic Substances) · NASDAQ
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology company developing therapies for blood coagulation disorders. The company focuses on treatments intended to address rare bleeding conditions, including Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its common stock trades on the Nasdaq Global Select Market under the symbol COAG.
The company's lead program is sutacimig (HMB-001), a bispecific antibody being developed as a prophylactic therapy for Glanzmann thrombasthenia and Factor VII deficiency. Hemab's work is centered on coagulation biology and the development of therapeutic candidates for patients with inherited or rare bleeding disorders.
Hemab reports one operating segment focused on the research and development of prophylactic therapeutics for bleeding disorders. As a clinical-stage biotechnology issuer, its operating model is based on advancing drug candidates through research, development, and regulatory processes before any potential commercialization.
Frequently Asked Questions
HEMAB THERAPEUTICS HOLDINGS investment returns
How much would $1,000 invested in HEMAB THERAPEUTICS HOLDINGS be worth today?
Limited historical data is available for COAG. The stock has been trading since 2026-05-01.
Has HEMAB THERAPEUTICS HOLDINGS outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare COAG performance over available time periods.
What is HEMAB THERAPEUTICS HOLDINGS's average annual return?
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
